Stock Scorecard



Stock Summary for MaxCyte Inc (MXCT) - $4.32 as of 3/28/2024 11:40:27 AM EST

Total Score

8 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MXCT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MXCT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MXCT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for MXCT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for MXCT

Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket - BYND Cannasoft Enterprise ( NASDAQ:BCAN ) , Aquestive Therapeutics ( NASDAQ:AQST ) 3/20/2024 12:20:00 PM
Harrow Posts Weak Q4 Results, Joins TeraWulf, Nasdaq And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - TeraWulf ( NASDAQ:WULF ) , Nasdaq ( NASDAQ:NDAQ ) , Harrow ( NASDAQ:HROW ) 3/20/2024 9:32:00 AM
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday - NVIDIA ( NASDAQ:NVDA ) 3/13/2024 12:51:00 PM
Bitcoin, Ethereum, Dogecoin Drop Amid Hotter-Than-Expected CPI Data: Analyst Says The Next Key Level For King Crypto Is $83K; Biden's Approval Ratings Rise Amid Shift - Top Headlines Today While US Was Sleeping 3/13/2024 12:38:00 PM
Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session - Beauty Health ( NASDAQ:SKIN ) 3/13/2024 10:16:00 AM
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance 3/12/2024 8:05:00 PM
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences 2/9/2024 1:05:00 PM
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences - MaxCyte ( NASDAQ:MXCT ) 2/9/2024 1:05:00 PM
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen's Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers 1/30/2024 1:05:00 PM
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs 1/23/2024 1:05:00 PM

Financial Details for MXCT

Company Overview

Ticker MXCT
Company Name MaxCyte Inc
Country USA
Description N/A
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 12/31/2023
Next Earnings Date 5/8/2024

Stock Price History

Last Day Price 4.32
Last Day Price Updated 3/28/2024 11:40:27 AM EST
Last Day Volume 616,486
Average Daily Volume 619,092
52-Week High 5.54
52-Week Low 2.45
Last Price to 52 Week Low 76.33%

Valuation Measures

Trailing PE N/A
Industry PE 34.70
Sector PE 43.11
5-Year Average PE -24.36
Free Cash Flow Ratio 2.67
Industry Free Cash Flow Ratio 50.55
Sector Free Cash Flow Ratio 89.92
Current Ratio Most Recent Quarter 10.65
Total Cash Per Share 1.62
Book Value Per Share Most Recent Quarter 2.23
Price to Book Ratio 1.95
Industry Price to Book Ratio 8.75
Sector Price to Book Ratio 9.32
Price to Sales Ratio Twelve Trailing Months 11.25
Industry Price to Sales Ratio Twelve Trailing Months 4.29
Sector Price to Sales Ratio Twelve Trailing Months 2.00

Share Statistics

Total Shares Outstanding 104,129,000
Market Capitalization 449,837,280
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -60.89%
Reported EPS 12 Trailing Months -0.37
Reported EPS Past Year -0.37
Reported EPS Prior Year -0.23
Net Income Twelve Trailing Months -37,923,000
Net Income Past Year -37,923,000
Net Income Prior Year -23,571,000
Quarterly Revenue Growth YOY 26.10%
5-Year Revenue Growth 10.37%

Balance Sheet

Total Cash Most Recent Quarter 168,288,000
Total Cash Past Year 168,288,000
Total Cash Prior Year 227,339,600
Net Cash Position Most Recent Quarter 168,288,000
Net Cash Position Past Year 163,371,000
Long Term Debt Past Year 4,917,000
Long Term Debt Prior Year 4,917,000
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 0.98
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 232,167,000
Total Stockholder Equity Prior Year 253,968,000
Total Stockholder Equity Most Recent Quarter 232,167,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal -0.12
20-Day Bollinger Lower Band 4.00
20-Day Bollinger Middle Band 4.69
20-Day Bollinger Upper Band 5.37
Beta 1.04
RSI 52.41
50-Day SMA 4.29
200-Day SMA 0.00

System

Modified 3/27/2024 2:05:09 AM EST